Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-16

Clinical Trial Update: Safety and Tolerability of a Timolol Releasing Intraocular Implant in Subjects With Primary Open-angle Glaucoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and tolerability of a timolol-releasing intraocular implant in adults with primary open-angle glaucoma; the study was termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Timolol-releasing intraocular implant (timolol-releasing intraocular implant)

Snippet

Sponsor: EyeD Pharma | Conditions: Primary Open-angle Glaucoma | Phase 1 | Status: TERMINATED